NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


SEARCH JOBS










 Company News
Arno Therapeutics Announces Dosing of First Patient in Phase I of AR-12, a PDK-1 Inhibitor Targeting the PI3K/Akt Pathway 8/27/2009 11:06:05 AM    More...
Arno Therapeutics Announces Enrollment of First Patient in Phase II Study of AR-67 (formerly DB-67) in Patients with Myelodysplastic Syndrome 7/23/2009 8:29:41 AM    More...
Arno Therapeutics Announces Three Poster Presentations at American Society of Clinical Oncology Annual Meeting 5/27/2009 9:31:14 AM    More...
FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway 5/11/2009 8:54:57 AM    More...
Arno Therapeutics Reports 2008 Year-End Financial Results 3/31/2009 9:11:34 AM    More...
FDA Accepts IND for Arno Therapeutics' Pan-DAC / Akt Inhibitor, AR-42 3/17/2009 7:14:11 AM    More...
Arno Therapeutics Announces Third Quarter 2008 Financial Results 11/14/2008 8:19:28 AM    More...
Arno Therapeutics Appoints William F. Hamilton to Board of Directors 10/30/2008 8:34:22 AM    More...
Arno Therapeutics Announces Appointment of Roger G. Berlin, MD, as Chief Executive Officer and Director 9/3/2008 10:58:37 AM    More...
Arno Therapeutics Announces Second Quarter 2008 Financial Results 8/19/2008 10:35:43 AM    More...
12